Clinical trial
Molecular Genetic Lesions and Clinical Outcomes in Children With Acute…
NCT00003291 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003291 |
|---|---|
| Title | Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia |
| Official title | Molecular Genetic Lesions and Clinical Outcome in Pediatric ALL Patients |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Leukemia |
| Intervention type | Genetic, Other |
| Interventions | cytogenetic analysis, mutation analysis, laboratory biomarker analysis |
| Enrollment | 200 |
| Start date | Mar 1, 1998 |
| Primary completion | Mar 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 8, 2014 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: